Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz) for the treatment...

yesterday New Drug Approvals

Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo (axatilimab-csfr) 9 mg and 22 mg Vial Sizes

WILMINGTON, Del. and WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Incyte (Nasdaq:INCY) and Syndax Pharmaceuticals (Nasdaq:SNDX) today...

2 days ago New Drug Approvals

Psychological Distress in Teen Years Tied to Later Economic Outcomes

Psychological distress in adolescence is tied to economic outcomes 10 years later, according to a study published online Jan. 16 in PLOS Medicine.Nathaniel...

today News for Health Professionals

Teen Stress Is Expensive, Experts Say -- So How Can We Reduce It?

Stressed-out teenagers appear to be dragging down the U.S. economy, a new study says. Teenagers suffering from anxiety or depression are less likely to...

today Medical

Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer

For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab emtansine (T-DM1) improves overall...

today News for Health Professionals

Cancer Mortality Continued to Decline Through 2022

Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among women, according to the Cancer Statistics,...

today News for Health Professionals

TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the addition of lenvatinib and pembrolizumab...

today News for Health Professionals

FDA Proposes Nicotine Cap To Help Curb Cigarette Addiction

A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far less addictive by reducing their...

today Medical

Teen Lifestyles Were Less Healthy in 2023 Compared to 2013, CDC Report Shows

U.S. teenagers still struggle to make healthy choices when it comes to diet, exercise and sleep, a new Centers for Disease Control and Prevention report...

today Medical

So, Who Benefits From New Cancer Drugs?

Cutting-edge targeted therapies are pushing back the line between life and death for cancer patients. However, these targeted cancer drugs frequently...

today Medical

FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA

FDA is warning health care professionals not to use unapproved epinephrine nasal solutions manufactured by BPI Labs LLC, in Largo, Fla., and Endo...

today FDA Alerts

Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo (tabelecleucel)

(BUSINESS WIRE) January 16, 2025 -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr...

yesterday New Drug Applications

Updated Guidelines for Preventing Osteoporosis-Related Fractures Released

All women 65 and older should continue to be screened for osteoporosis, the nation’s leading preventive health panel says in an updated recommendation. The...

2 days ago Medical

Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)

(Newsfile Corp. - January 13, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with...

3 days ago Clinical Trials

Datopotamab Deruxtecan Granted Priority Review in the US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted Priority...

3 days ago Clinical Trials

Recently Added

Recently added consumer and prescribing information: Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl, Emrosi

For Consumers

For Professionals

For Researchers

Pharmaceutical Company Directory

Latest FDA New Drug Approvals

Opdivo Qvantig Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) is a programmed death receptor-1 (PD-1)-blocking antibody and hyaluronidase combination...
Alyftrek Alyftrek (deutivacaftor, tezacaftor and vanzacaftor) is a next-in-class, triple combination cystic fibrosis transmembrane conductance...
Alhemo Alhemo (concizumab-mtci) is a tissue factor pathway inhibitor (TFPI) antagonist indicated for routine prophylaxis to prevent or reduce the...

More FDA approvals

Drugs in Development (Not yet approved)

Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development

Drug Information

Tools

News & Alerts

Professionals

Top 100 Drugs

Recommended Content

Find Drugs & Conditions

FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

So, Who Benefits From New Cancer Drugs?

Recently Added

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

Drugs in Development (Not yet approved)

Drug Information

Tools

News & Alerts

Professionals

Top 100 Drugs